Search

everythinglearnresearchcommunity

for

Search:↓

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Acinetobacter strain A1-4-2 can safely clean water pollutants.

Five FDA-approved drugs may help block COVID-19 virus entry.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

34% of patients on hepatitis C treatment had reversible skin issues.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Valproic acid is a more effective treatment for vomiting in Alexander disease than other medications, with few side effects.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Some people have severe allergic reactions to anthelminthic drugs, but these are often due to the parasites, not the drugs.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Tofacitinib treatment is used for teenagers with alopecia areata.

Acyzol could help treat conditions caused by zinc deficiency.

Cepharanthine shows promise as a COVID-19 treatment.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

A woman's hair loss was probably caused by the antifungal drug anidulafungin.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Aminopterin effectively improves skin conditions but has toxic side effects that need careful monitoring.